医学
多发病率
队列
公共卫生
入射(几何)
环境卫生
疾病
慢性病
前瞻性队列研究
队列研究
流行病学转变
代群效应
糖尿病
流行病学
死亡率
医疗保健
全球卫生
老年学
生活质量(医疗保健)
共病
疾病管理
梅德林
重症监护医学
慢性病
长期护理
疾病负担
人口学
儿科
发达国家
医疗保健系统
疾病负担
2型糖尿病
作者
Xin Hong,Yuefan Shen,Chenchen Wang,Qing Ye,Weiwei Wang,Y Chen,Hao Xu,Jie Wu,Dai Lijuan,X Cheng,Ci Song,Chong Shen,Juncheng Dai,Hongxia Ma,Nan Zhou,Dong Hang,Guangfu Jin
摘要
As a major global public health threat, non-communicable diseases (NCDs), such as cardiovascular disease, cancer, chronic respiratory disorder, and diabetes mellitus, are characterized by high treatment expenditures, poor prognosis, and substantial societal burdens [1–3]. Annually, NCDs account for ∼41 million deaths, equivalent to 74% of global mortality [4]. In China, the mortality rate from NCDs increased from 534.6 to 748.0 per 100 000 people from 1990 to 2021 will continue to increase in the near future [5]. Notably, the incidence of multimorbidity—the coexistence of two or more NCDs within an individual—has been steadily increasing in China, contributing to elevated mortality rates, reduced quality of life, and heightened strain on healthcare resources [6–8]. The mechanisms and outcomes of multimorbidity vary across disease clusters but remain poorly understood [9, 10]. Prospective evidence elucidating modifiable drivers of multimorbidity is critically required to inform the targeted prevention frameworks and evidence-based management paradigms for this public health challenge.
科研通智能强力驱动
Strongly Powered by AbleSci AI